Next Article in Journal
Professor Barry V.L. Potter: Winner of the 2018 Tu Youyou Award in Honor of the Co-Recipient of the 2015 Nobel Prize in Physiology or Medicine for Her Discoveries Concerning a Novel Therapy against Malaria
Previous Article in Journal
Synthesis of a Novel Fluorescent Ruthenium Complex with an Appended Ac4GlcNAc Moiety by Click Reaction
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessArticle
Molecules 2018, 23(7), 1650; https://doi.org/10.3390/molecules23071650

Comprehensive Metabolomics Analysis of Xueshuan Xinmaining Tablet in Blood Stasis Model Rats Using UPLC-Q/TOF-MS

1
School of Pharmaceutical Sciences, Jilin University, Fujin Road 1266, Changchun 130021, China
2
Department of Pathogenic Biology, Basic Medical College, Jilin University, Xinmin Street 126, Changchun 130021, China
*
Authors to whom correspondence should be addressed.
Received: 6 June 2018 / Revised: 3 July 2018 / Accepted: 3 July 2018 / Published: 6 July 2018
(This article belongs to the Section Analytical Chemistry)
Full-Text   |   PDF [4655 KB, uploaded 6 July 2018]   |  

Abstract

Blood stasis syndrome (BSS) is one of the most common Chinese medicine patterns in coronary heart disease. Our previous work proved that Xueshuan Xinmaining Tablet (XXT) could treat blood stasis through regulating the expression of F13a1, Car1 and Tbxa2r. In the current study, the effect and mechanism of XXT on BSS was comprehensively and holistically investigated based on a metabolomics approach. Urine and plasma samples of 10 BBS rats treated with XXT (XT), 9 BSS model rats (BM) and 11 normal control (NC) rats were collected and then determined by UPLC-Q/TOP-MS. Multivariate analyses were applied to distinguish differentiate urinary and plasma metabolite patterns between three groups. Results showed that a clear separation of three groups was achieved. XT group was located between BM group and NC group, and showing a tendency of recovering to NC group, which was consistent with the results of hemorheological studies. Some significantly changed metabolites like cortexolone, 3α,21-dihydroxy-5β-pregnane-11,20-dione and 19S-hete and leukotriene A4, chiefly involved in steroid hormone biosynthesis, arachidonic acid metabolism and lipid metabolism, were found and identified to explain the mechanism. These potential markers and their corresponding pathways will help explain the mechanism of BSS and XXT treatment. This work also proves that metabolomics is effective in traditional Chinese medicinal research. View Full-Text
Keywords: blood stasis syndrome; Xueshuan Xinmaining tablet; UPLC-Q/TOF-MS; rats; metabolomics blood stasis syndrome; Xueshuan Xinmaining tablet; UPLC-Q/TOF-MS; rats; metabolomics
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Tan, J.; Wang, C.; Zhu, H.; Zhou, B.; Xiong, L.; Wang, F.; Li, P.; Liu, J. Comprehensive Metabolomics Analysis of Xueshuan Xinmaining Tablet in Blood Stasis Model Rats Using UPLC-Q/TOF-MS. Molecules 2018, 23, 1650.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top